UnitedHealth Group stock has surged more than 20% this month after Warren Buffett’s Berkshire Hathaway and other hedge fund managers took a stake in the company. Despite facing a DOJ investigation and suspending full-year financial guidance, UnitedHealth Group has attractive valuation and a strong balance sheet with over $32 billion in cash. However, EPS revisions have been declining, with FY26 estimates dropping nearly 30% in the last two months. Investors may want to consider fading the recent rally as UNH currently holds a Zacks Rank #5 (Strong Sell). Consider the iShares U.S. Healthcare Providers ETF as an alternative for exposure to UNH.

Read more at Zacks Investment Research.: Buy, Hold, or Fade the Recent Rally in UnitedHealth Group (UNH) Stock? – August 18, 2025